我要投票 江中在中草药行业中的票数:13
· 外 推 电 报 ·
2024-11-22 21:13:51 星期五

【江中是哪个国家的品牌?】

江中是什么牌子?「江中」是江西江中制药(集团)有限责任公司旗下著名品牌。该品牌发源于江西,由创始人卢小青在1998期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

江中牌健胃消食片,解决日常出现的消化不良问题,成人主要症状表现为脾胃虚弱所导致的食积、不思饮食、脘腹胀满等,儿童主要症状表现为不吃饭、厌食、挑食等。配方中的山药、山楂、陈皮、麦芽等都是食品原料,药食同源,安全放心,上市十余年来深受广大消费者的青睐,是日常助消化领域的首选品牌

2005-2011年,连续7年荣获中成药OTC消化类销量第一,2009年度荣获非处方药单品销量冠军,2007年荣获“中国最具影响力品牌TOP10”(医药类)。

【药品名称】通用名称:健胃消食片
汉语拼音:JianweiXiaoshiPian
【成份】太子参、陈皮、山药、炒麦芽、山楂。辅料为蔗糖、糊精、枸橼酸、山楂香精、硬脂酸镁。
【性状】本品为浅棕黄色的薄膜衣异形片,除去包衣后显浅棕黄色;气微香,味微甜、酸。
【功能主治】健胃消食。用于脾胃虚弱所致的食积,症见不思饮食、嗳腐酸臭、脘腹胀满;消化不良见上述证候者。
【规格】每片重0.8克(薄膜衣片)
【用法用量】口服,一次3片,一日3次。
【不良反应】尚不明确。
【禁忌】尚不明确。
【注意事项】
1.饮食宜清淡,忌酒及辛辣、生冷、油腻食物。
2.有高血压、心脏病、肝病、糖尿病、肾病等慢性病严重者应在医师指导下服用。
3.儿童、孕妇、哺乳期妇女、年老体弱者应在医师指导下服用。
4.服药3天症状无缓解,应去医院就诊。
……

江西江中制药(集团)有限责任公司(简称“江中集团”)系江西省国有资产监督管理委员会控股集团,是以“江中药业股份有限公司”和“江西中江地产股份有限公司”两家上市公司为运营主体,集医药制造、保健食品、房地产于一体的现代化综合型企业。江中集团是制药行业唯一一家拥有两个国家工程研究中心的企业,与中国军事医学科学院联合建立“蛋白质药物国家工程研究中心”;与江西中医学院联合建立“中药固体制剂制造技术国家工程中心”。在江西首家创建“企业博士后科研工作站”,研究开发具有市场重大价值,拥有自主知识产权,具备国际竞争力的创新药物。如抗艾滋病、乙肝病毒新药-二咖啡酰奎尼酸(简称IBE5)等。

江中集团以经营中药OTC和保健食品为主,江中复方草珊瑚含片、江中健胃消食片、江中亮嗓、系列江中感冒药、咳嗽药、初元、参灵草、杞浓酒等深受消费者的喜爱。其中,江中复方草珊瑚含片、江中健胃消食片分别荣获“2005百姓信赖药品品牌”。2007年,素有“中国品牌奥斯卡”之称的“世界品牌实验室2007(第四届)中国品牌年度大奖”评选在香港揭晓,“江中”荣获“2007年中国最具影响力品牌TOP10”(医药类)荣誉称号,行业排名第三。集团所属子公司江中药业股份有限公司先后被国家科技部、国务院国资委、中华全国总工会授予“国家创新型企业”、江西省人民政府授予“江西工业优强企业”、江西省工信委授予“2009年度全省节能先进单位”;江西中江地产股份有限公司紫金城楼盘被南昌市房管局授予“第五届节能环保和绿化环境金奖”等荣誉。

江中集团凭借人才优势、科研优势、管理优势,实施“大市场、大品牌”战略,通过产品经营、品牌经营、资本与资产经营,不断提高企业核心竞争力,力将OTC类药品业务打造成为中国第一。

以上信息只供参考,以企业公布为准。查看>>

英文翻译:Jiangzhong brand Jianwei Xiaoshi tablet can solve the problem of dyspepsia in daily life. The main symptoms of adults are accumulation of food caused by weakness of spleen and stomach, not thinking about food, fullness of abdomen, etc. the main symptoms of children are not eating, anorexia, pickiness, etc. Chinese yam, hawthorn, tangerine peel and malt in the formula are all food raw materials. They are of the same origin, safe and reassuring. They have been favored by consumers for more than ten years since they went on the market. They are the first choice brand in the field of daily digestion assistance in 2005-2011. They have won the first sales volume of OTC digestion of Chinese patent medicine for seven consecutive years. In 2009, they won the champion of over-the-counter drug sales volume. In 2007, they won the "most influential product in China" Brand TOP10 "(Medicine). [drug name] general name: Jianwei Xiaoshi tablet Chinese Pinyin: Jianwei Xiaoshi Pian [ingredients] Pseudostellaria, tangerine peel, yam, fried malt, hawthorn. Excipients are sucrose, dextrin, citric acid, hawthorn flavor and magnesium stearate. [properties] this product is a light brown yellow film coated special-shaped tablet. After removing the coating, it will appear light brown yellow; the air is slightly fragrant, and the taste is slightly sweet and sour. [function indications] invigorating stomach and eliminating food. It is used for the food accumulation caused by the weakness of spleen and stomach. The symptoms include not thinking about food, belching, sour and smelly, fullness of the abdomen, and dyspepsia. [Specification] each tablet weighs 0.8g (film coated tablet) [usage and dosage] oral, 3 tablets at a time, 3 times a day. [adverse reactions] are not clear. [taboo] is not clear. [notes] 1. The diet should be light, and avoid alcohol and spicy, cold and greasy food. 2. Those with serious chronic diseases such as high blood pressure, heart disease, liver disease, diabetes, kidney disease should be taken under the guidance of doctors. 3. Children, pregnant women, lactating women, the elderly and the weak should take it under the guidance of doctors. 4. If the symptoms are not relieved after taking the medicine for 3 days, you should go to the hospital for treatment Jiangxi Jiangzhong Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "Jiangzhong group") is a holding group of Jiangxi Provincial State owned assets supervision and Administration Commission. It is a modern comprehensive enterprise with two listed companies of "Jiangzhong Pharmaceutical Co., Ltd." and "Jiangxi Zhongjiang Real Estate Co., Ltd." as its operation main body, integrating pharmaceutical manufacturing, health food and real estate. Jiangzhong group is the only enterprise in the pharmaceutical industry with two national engineering research centers. It has jointly established the "National Engineering Research Center for protein drugs" with the Chinese Academy of Military Medical Sciences and the "National Engineering Center for solid preparation manufacturing technology of traditional Chinese medicine" with Jiangxi College of traditional Chinese medicine. It is the first enterprise postdoctoral research station in Jiangxi Province to develop innovative drugs with great market value, independent intellectual property rights and international competitiveness. Such as anti AIDS, hepatitis B new drug - dicaffeoylquinic acid (ibe5) and so on. Jiangzhong group mainly deals in TCM OTC and health food. Jiangzhong compound Caoshanhu buccal tablet, Jiangzhong Jianwei Xiaoshi tablet, Jiangzhong Liangsheng, a series of Jiangzhong cold medicine, cough medicine, Chuyuan, shenlingcao and Qinong liquor are deeply loved by consumers. Among them, Jiangzhong compound Caoshanhu buccal tablet and Jiangzhong Jianwei Xiaoshi tablet were awarded "2005 popular trust drug brand" respectively. In 2007, the "world brand laboratory 2007 (the fourth) China brand annual award", known as "China brand Oscar", was announced in Hong Kong. Jiangzhong won the honorary title of "top 10 most influential brand in China (medicine category) in 2007, ranking third in the industry. Jiangzhong Pharmaceutical Co., Ltd., a subsidiary of the group, has been awarded "national innovative enterprise" by the Ministry of science and technology, the state owned assets supervision and Administration Commission of the State Council, the all China Federation of trade unions, the people's Government of Jiangxi Province, the industrial and Information Technology Commission of Jiangxi Province, the "advanced energy saving unit of 2009"; Zijincheng real estate of Jiangxi Zhongjiang Real Estate Co., Ltd. has been awarded by Nanchang Real Estate Co., Ltd The fifth gold award for energy conservation, environmental protection and green environment was awarded by the authority. With the advantages of talents, scientific research and management, Jiangzhong group has implemented the strategy of "big market, big brand". Through product management, brand management, capital and asset management, Jiangzhong group has continuously improved the core competitiveness of the enterprise, striving to make OTC medicine business the first in China. The above information is for reference only, subject to the announcement of the enterprise. View & gt; & gt;

本文链接: https://www.waitui.com/brand/f26522e2f.html 联系电话:0791-88164199

千城特选小程序码

7×24h 快讯

梅花生物:拟105亿日元收购协和发酵旗下的食品氨基酸等业务及资产

36氪获悉,梅花生物发布公告,全资子公司新加坡公司拟以105亿日元(折合人民币约5亿元左右)收购Kirin Holdings Company, Limited(简称“麒麟控股”,东京证券交易所上市公司,股票代码2503.T)的全资子公司Kyowa Hakko Bio Co., Ltd.(协和发酵株式会社,简称“协和发酵”)旗下的食品氨基酸、医药氨基酸、母乳低聚糖业务及资产。

2小时前

三鑫医疗:获得医疗器械注册证

36氪获悉,三鑫医疗发布公告,公司及控股子公司宁波菲拉尔医疗用品有限公司于近日分别获得了国家药监局颁发的血液透析滤过器、一次性使用右心吸引头《医疗器械注册证》。

2小时前

上海电影:拟收购上影元19%股权

36氪获悉,上海电影发布公告,公司拟以现金形式收购控股股东上影集团、上美影分别持有的公司控股子公司上影元(上海)文化科技发展有限公司(简称上影元)14%、5%股权,对应转让价格预计分别为不超过4902.8万元、1751万元。本次交易完成后,上影元股权结构为公司持股70%,上美影持股30%。

2小时前

英国监管机构拟调查苹果与谷歌的移动生态系统活动

英国竞争与市场管理局(CMA)11月22日发布声明称,正考虑根据明年生效的数字市场竞争新规优先调查苹果和谷歌的移动生态系统活动。CMA独立调查小组的研究发现,苹果和谷歌在移动生态系统形成了实际上的“双头垄断”,包括移动设备上的操作系统、应用商店和网络浏览器。该小组认为,苹果的政策阻碍了移动浏览器的创新。CMA表示,将在当地时间12月13日前邀请公众就上述临时调查结果发表评论,预计将在明年3月做出最终决定。(界面)

2小时前

​中晟高科:拟4.57亿元出售中晟新材100%股权

36氪获悉,中晟高科发布公告,公司通过在产权交易中心公开挂牌转让的方式,出售持有的中晟新材100%股权。在首次挂牌信息发布期限内征集到意向受让方泷祥投资,本次标的资产交易对方确定为泷祥投资,交易对价确定为4.57亿元。

2小时前

本页详细列出关于999三九的品牌信息,含品牌所属公司介绍,999三九所处行业的品牌地位及优势。
咨询